3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
3
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
42
Lymphoid
37
Plasma cell
28
Gynecologic
23
Myeloid
22
Genitourinary
22
Dermatologic
20
Sarcoma
15
CNS
15
Breast
15
Classical hematology
6
Gastrointestinal
5
Other neoplasm
3
Head & Neck
3
Thoracic
2
Other
2
Conditions
Obesity
298
Mucositis
116
Neoplasms
108
Breast Neoplasms
87
Overweight
80
Sexual Dysfunction, Physiological
74
Polycystic Ovary Syndrome
71
Dyspnea
48
Motor Activity
46
Constipation
45
Head and Neck Neoplasms
42
Weight Loss
36
Prostatic Neoplasms
32
Pain
29
Stomatitis
26
Endometrial Neoplasms
23
Opioid-Induced Constipation
22
Multiple Endocrine Neoplasia Type 1
20
Diabetes Mellitus
20
Lung Neoplasms
18
Colorectal Neoplasms
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Sexual Dysfunctions, Psychological
15
Depression
15
Cardiovascular Diseases
15
Anxiety Disorders
15
Sedentary Behavior
13
Insulin Resistance
13
Infertility
13
Cancer-related Fatigue
13
Interventions
fish oil triglycerides
1
Probiotics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Infections
×
Other
×
Clear all
NCT03785938
2018-12-24
MaCROS
University of Leeds
Phase NA
Unknown
40 enrolled
NCT00533078
2015-07-23
LUNCH1
Insel Gruppe AG, University Hospital Bern
Phase 2
Completed
14 enrolled